Home » Business News » 2014 » May » May 9, 2014

Biotie: Change in the number of votes

May 9, 2014 - London

BIOTIE THERAPIES CORP.                Stock Exchange Release          9 May 2014 at 09.05 am

Biotie: Change in the number of votes

Biotie Therapies Corp. ("Biotie" or the "Company") has conveyed Biotie shares held as treasury shares pursuant to the Stock Option Plan 2011 and the Equity Incentive Plan 2011 as follows:

Shares conveyed Cumulative shares conveyed since 2 January 2014 Remaining shares to be conveyed
155,000 1,246,250 2,075,410

Under the Stock Option Plan 2011, the owners of the stock options may subscribe for a maximum total of 7,401,000 new shares in the Company or existing shares held by the Company. A total of 155,000 shares have been subscribed for during the period 4 April 2014 and 8 May 2014 and 155,000 of the treasury shares will be used for these share subscriptions. The subscription price of EUR 0.01 per share has been fully paid by the employee and the EUR 1,550 funds received will be credited to the Company's reserve for non-restricted equity.

Based on the Equity Incentive Plan 2011 no shares have been conveyed during the period 4 April 2014 and 8 May 2014.

The conveyed shares previously held as treasury shares have not carried any voting rights. The conveyance does not affect the number of registered shares. After the conveyances the changes are as follows:

Increase in number of outstanding shares Total amount of
voting rights
Number of the
Company's shares held
by the Group
Total number
of registered
155,000 447,520,899 8,511,499 456,032,398

Turku, 9 May 2014

Biotie Therapies Corp.
Timo Veromaa, President and CEO

For further information, please contact:
Virve Nurmi, Investor Relations Manager, Biotie Therapies Corp.
tel. +358 2 274 8900, e-mail:
NASDAQ OMX Helsinki Ltd
Main Media 

This announcement is distributed by NASDAQ OMX Corporate Solutions on behalf of NASDAQ OMX Corporate Solutions clients.
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: Biotie Therapies Oyj via Globenewswire



Comment on this story